Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer

Center of Personalized Medicine, Pirogova

Status: Unknown

Conditions: Breast Cancer-specific Survival

Treatments: Drug: neoadjuvant/adjuvant therapy

Study type: Observational

Funder types: Other

Identifiers

NCT04798976

20210312

Details and patient eligibility

About

A population-based case-cohort study of breast cancer-specific survival among all first invasive breast cancer cases

Enrollment: 3,000 estimated patients

Sex: Female

Ages: Under 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

All women with stage I-III disease who survived at least 12 months post-diagnosis

Exclusion criteria

Unknown cause of death Treatment outside the region (thus precluding the treatment assessment)

Trial design

3,000 participants in 2 patient groups

CDSS (MedicBK) Analysis

Treatment:

Drug: neoadjuvant/adjuvant therapy

Core Laboratory Analysis

Treatment:

Drug: neoadjuvant/adjuvant therapy